The global paper diagnostics market is expanding fast, as demand for rapid testing and accurate diagnosis continues to rise in response to increase in cases of cancer, autoimmune diseases, and inflammatory diseases, worldwide, finds Fact.MR, in a new study. Due to their benefits such as ease of fabrication, affordability, sensitivity, reproducibility, and low limits of detection, paper diagnostics are highly sought-after in the healthcare and diagnostics segment.
According to the World Health Organization (WHO), there were 18.1 million new cancer cases and 9.6 million deaths in 2018, globally. This has resulted in a surge in demand for paper diagnostics for early detection of cancer over the past decade.
Key Points Covered in Paper Diagnostics Industry Survey
- Market Estimates and Forecasts 2016-2031
- Key drivers and restraints shaping market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Paper Diagnostics Market and How to Navigate
- Recommendation and Key Winning Strategy
Request Sample https://www.factmr.com/connectus/sample?flag=S&rep_id=5454
Key Takeaways from Paper Diagnostics Market Report
- Lateral flow assays are expected to witness the considerably high demand over the forecast period between 2020 and 2030
- Hospitals & clinics segment is expected to remain the primary end user of paper diagnostics through the forecast period
- North America will lead the global paper diagnostics market with its epicenter in the U.S.
- East Asia will emerge as another lucrative region exhibiting impressive growth throughout the forecast period
- The outbreak of COVID-19 is expected to moderately impact the growth of the paper diagnostics market till the end of the next year
“According to the National Center for Biotechnology Information (NCBI), autoimmune diseases are among the leading causes of death among young and middle-aged woman in the United States, and the prevalence rate ranges from less than 5 per 100,000 (e.g. chronic active hepatitis, uveitis) to more than 500 per 100,000 (grave disease, rheumatoid arthritis, thyroiditis). Against this backdrop, demand will continue rising steadily as focus remains on prompt diagnosis of autoimmune diseases,”said a Fact.MR analyst.
Paper Diagnostics Market – Segmentation
Fact.MR’s research study assesses the global paper diagnostics market in terms of product type, end user, and region. This report presents extensive market dynamics and trends associated with different segments of the market, and their influence on the growth prospects of the global paper diagnostics market.
Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=5454
Product |
- Lateral Flow Assays
- Dipsticks
- Paper-based Micro Fluidics
|
End User |
- Hospitals & Clinics
- Home Care Settings
|
Region |
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
|
Buy Now https://www.factmr.com/checkout/5454
Key Questions Answered in Fact.MR’s Paper Diagnostics Market Report
-
- Which are the most lucrative markets for paper diagnostics?
- Which factors will impact paper diagnostics market growth?
-
- How will changing trends impact the strategy of market players?
- How can market players capture the low-hanging opportunities?
- Which companies are leading the paper diagnostics market?
- What are the winning strategies of stakeholders in the paper diagnostics market?
Paper Diagnostics Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the paper diagnostics market report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the paper diagnostics market during the forecast period.
Country-specific valuation on demand for paper diagnostics has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
For More Insights: https://www.newswire.co.kr/newsRead.php?no=927193
Paper Diagnostics Market: Research Methodology
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the paper diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the paper diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the paper diagnostics market report as a primary resource.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates